A. Kaag

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

Philippe Bédard, L. Siu, J. Rodon, 2015, British Journal of Cancer.

A phase 1b dose-escalation study of BYL719 plus binimetinib (MEK162) in patients with selected advanced solid tumors.

J. Desai, D. Juric, J. Soria, 2014 .